Unresected colorectal liver metastases: Prognostic value of laboratory variables;Métastases hépatiques non opérées des cancers colorectaux: Valeur pronostique des variables biologiques

Gastroenterologie Clinique et Biologique

Volumn 25, Issue 11, 2001, Pages 962-966

  Friedberg, Bruno ^a   Watine, Joseph ^b,d   Miédougé, Marcel ^c  

^a Laboratoire de Biologie Polyvalente   (France)

^b Centre Hospitalier General   (France)

^c CHU PURPAN   (France)

^d HÔPITAL DU BOCAGE   (France)

Author keywords

Albumin; Alkaline phosphatase; Bilirubin; Carcino embryonic antigen; Colorectal cancer; Liver metastases; Prognosis; Prothrombin time; Survival

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN; CARCINOEMBRYONIC ANTIGEN;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; COLORECTAL CANCER; HUMAN; LABORATORY TEST; LIVER METASTASIS; PROGNOSIS; PROTHROMBIN TIME;

ALKALINE PHOSPHATASE; BILIRUBIN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; PROGNOSIS; PROTHROMBIN TIME; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; TUMOR MARKERS, BIOLOGICAL;

EID: 19244383445     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy
2. Intraoperative determinants of unresectability for patients with colorectal hepatic metastases
3. Indicators for treatment strategies of colorectal liver metastases
4. The future of prognostic factors in outcome prediction for patients with cancer
5. The CONSORT statement: Revised recommendations for improving the quality of reports of parallelgroup randomized trials
6. CEA as an independent prognostic factor of recurrence and survival in patients resected for colorectal liver metastases. A systematic review
7. La biologie clinique fondée sur des preuves ou evidence based laboratory medicine
8. Systematic reviewing in laboratory medicine. Position paper from the IFCC committee on systematic reviewing in laboratory medicine
9. Dosage des marqueurs tumoraux
10. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases
11. Chimiothérapie intra-artérielle hépatique. Expérience de 200 cas
12. Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer. II. Treatment by intrahepatic chemotherapy
13. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
14. Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement
15. A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma
16. Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer
17. Factors influencing the natural history of colorectal liver metastases
18. Clinical practice and guidelines for the use of tumor markers in breast and colorectal cancer
19. Prognostic significance of pre-operative serum CA 19.9 assay in patients with colorectal carcinoma
20. The association of pre-operative serum tumor markers with Dukes' stage and survival in colorectal cancer
21. Reducing unnecessary laboratory use with new test request form: Example of tumour markers
22. Laying a firm foundation for interdisciplinary research endeavours